Navigation Links
Envera Appoints Michael McErlean Fermentation Manager
Date:5/22/2013

West Chester, PA (PRWEB) May 22, 2013

Envera announced today that Michael McErlean has joined the company as Fermentation Manager. Mr. McErlean has an extensive background in cell production and served in a variety of leadership positions throughout his career.

Mike Matheny, President and Owner of Envera stated, “We are very pleased to have Mike join our team”. “Mike’s background is perfectly suited to oversee our newly installed large scale fermentation and downstream processing equipment”, added Matheny. “Mike’s hands on experience optimizing production protocols, establishing preventative maintenance procedures, and troubleshooting equipment is exactly what we need for this stage of Envera’s growth”, concluded Matheny.

Mr. McErlean holds a Bachelor’s Degree from Millersville University. Mike’s professional career includes 18 years of experience divided between Centocor, Merck Sharp & Dohme, and Fibrocell Science. During his time with these companies Mike gained hands on experience running a variety of bioreactors and downstream equipment as well as the implementation of new procedures and processes. Michael was also responsible for the generation of SOP’s, departmental logistics, and Quality/Regulatory issues.

“I am pleased to join a technology based company that is making a difference in the world”, stated McErlean. “Envera’s focus on using naturally occurring microorganisms to replace harsh chemicals, remediate environmental waste, and promote the growth and health of plants and animals was particularly appealing to me”, added Mike. “I am eager to utilize the newly installed fermentation and downstream processing equipment to support Envera’s expanding business”, finished McErlean.

Mr. McErlean will be located at Envera’s West Chester, Pennsylvania corporate offices and can be reached at 484-593-4002 or mmcerlean(at)envera(dot)com.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10752565.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Envera Increases Scientific Staff
2. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
3. Elsevier / MEDai Appoints Tom Zajac as New President
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
6. BioStorage Technologies Appoints New Member to Board of Directors
7. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
8. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
9. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
10. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
11. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... ... 17, 2017 , ... Whitehouse Laboratories is excited to announce ... full series of ISO 80369 standard test procedures. The ISO 80369 series of ... delivery systems. With this recent expansion, Whitehouse Labs becomes one of the only ...
(Date:7/17/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced safety software company ... channel within the eHealth Solutions business segment to advance technology innovation across ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders (NDDs) are ... overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has been instrumental ... testing. , However, designing a custom panel for disease research requires hours ...
(Date:7/17/2017)... ... July 17, 2017 , ... Co-Diagnostics, Inc. (NASDAQ: CODX) ... both to manufacture and sell reagents used for diagnostic tests, has completed its ... in Sandy, Utah, Co-Diagnostics’ intellectual property and technologies are protected by five granted ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):